Robert Guigley joined Invitae as chief commercial officer in September 2023. In this role, Robert leads Invitae’s commercial strategy with a focus on driving profitable revenue growth, expanding the market, improving reimbursement levels and enhancing the service of clients and patients.
Robert is an industry veteran with more than 20 years of commercial experience spanning biotechnology, pharmaceuticals, diagnostics and genetic testing. He has a deep understanding of the long-term prospects of genetic information, along with extensive experience working with payors.
Most recently, Robert served as the chief commercial officer at Ambry Genetics where he was responsible for executing their commercial strategy and overseeing commercial sales, business development, client services, managing genetic specialists and expanding market access. He began his career in pharmaceutical sales at AstraZeneca, giving him a strong foundation in selling to physicians. He then migrated into diagnostics, leading sales and market access at Quest Diagnostics and Counsyl.
Robert earned his MBA at Boston University Questrom School of Business and his BS at the University of Pittsburgh, where he focused on economics, math and philosophy.